Spironolactone and Right ventricular hypertrophy - a phase IV clinical study of FDA data

Summary:

Right ventricular hypertrophy is reported as a side effect among people who take Spironolactone (spironolactone), especially for people who are female, 10-19 old, have been taking the drug for 6 - 12 months also take Furosemide, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Right ventricular hypertrophy when taking Spironolactone. It is created by eHealthMe based on reports of 119,147 people who have side effects when taking Spironolactone from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Right ventricular hypertrophy?

Right ventricular hypertrophy (right ventricular enlargement) is found to be associated with 232 drugs and 308 conditions by eHealthMe. Check the latest studies of Right ventricular hypertrophy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

119,147 people reported to have side effects when taking Spironolactone.
Among them, 50 people (0.04%) have Right ventricular hypertrophy.

Could Spironolactone cause Right ventricular hypertrophy?

Among these 50 people:

How long have people been on Spironolactone when they have Right ventricular hypertrophy? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 57.14 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 42.86 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Right ventricular hypertrophy when taking Spironolactone? *

  • female: 57.45 %
  • male: 42.55 %

What is the age of people who have Right ventricular hypertrophy when taking Spironolactone? *

  • 0-1: 8.89 %
  • 2-9: 0.0 %
  • 10-19: 24.44 %
  • 20-29: 11.11 %
  • 30-39: 13.33 %
  • 40-49: 15.56 %
  • 50-59: 8.89 %
  • 60+: 17.78 %

What are other drugs people take besides Spironolactone? *

  1. Furosemide: 16 people, 32.00%
  2. Omeprazole: 10 people, 20.00%
  3. Diazepam: 9 people, 18.00%
  4. Naloxone: 9 people, 18.00%
  5. Ondansetron: 9 people, 18.00%
  6. Zithromax: 9 people, 18.00%
  7. Methotrexate: 9 people, 18.00%
  8. Prednisone: 9 people, 18.00%
  9. Indomethacin: 9 people, 18.00%
  10. Folic Acid: 9 people, 18.00%

What are other side effects people have besides Right ventricular hypertrophy? *

  1. Hypotension (abnormally low blood pressure): 22 people, 44.00%
  2. Dyspnea (difficult or laboured breathing): 18 people, 36.00%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 18 people, 36.00%
  4. Diarrhea: 16 people, 32.00%
  5. Depressed Level Of Consciousness: 15 people, 30.00%
  6. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 15 people, 30.00%
  7. Fever: 14 people, 28.00%
  8. Tachypnea: 14 people, 28.00%
  9. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 14 people, 28.00%
  10. Ascites (accumulation of fluid in the abdominal cavity): 13 people, 26.00%

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 17 people, 34.00%
  2. Histiocytosis Haematophagic: 9 people, 18.00%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 8 people, 16.00%
  4. Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 8 people, 16.00%
  5. Hypokalemia (low potassium): 5 people, 10.00%
  6. Cardiac Failure: 5 people, 10.00%
  7. Constipation: 5 people, 10.00%
  8. Iron Deficiency Anaemia: 3 people, 6.00%
  9. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 3 people, 6.00%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and have Right ventricular hypertrophy?

- Check whether Right ventricular hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spironolactone:

Right ventricular hypertrophy treatments and more:

How severe was Right ventricular hypertrophy and when was it recovered:

Expand to all the drugs that have ingredients of spironolactone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Right ventricular hypertrophy:

Browse all the conditions that are associated with Right ventricular hypertrophy:


How the study uses the data?

The study uses data from the FDA. It is based on spironolactone (the active ingredients of Spironolactone) and Spironolactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: